Package 71335-2554-1

Brand: repaglinide

Generic: repaglinide
NDC Package

Package Facts

Identity

Package NDC 71335-2554-1
Digits Only 7133525541
Product NDC 71335-2554
Description

30 TABLET in 1 BOTTLE (71335-2554-1)

Marketing

Marketing Status
Marketed Since 2025-01-23
Brand repaglinide
Generic repaglinide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0b66565e-c13c-4b45-82d4-72df4696fc70", "openfda": {"nui": ["N0000175428", "N0000175448"], "unii": ["668Z8C33LU"], "rxcui": ["200257"], "spl_set_id": ["9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-2554-1)", "package_ndc": "71335-2554-1", "marketing_start_date": "20250123"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-2554-2)", "package_ndc": "71335-2554-2", "marketing_start_date": "20250123"}], "brand_name": "Repaglinide", "product_id": "71335-2554_0b66565e-c13c-4b45-82d4-72df4696fc70", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "71335-2554", "generic_name": "Repaglinide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": ".5 mg/1"}], "application_number": "ANDA207209", "marketing_category": "ANDA", "marketing_start_date": "20230322", "listing_expiration_date": "20261231"}